Ditchcarbon
  • Contact
  1. Organizations
  2. electroCore, Inc.
Public Profile
Medical Device Manufacturing
US
updated a month ago

electroCore, Inc.

Company website

electroCore, Inc., a pioneering medical technology company headquartered in the United States, focuses on non-invasive neuromodulation therapies. Founded in 2014, the company has made significant strides in the treatment of various neurological conditions, particularly through its flagship product, gammaCore. This innovative device is designed to deliver electrical stimulation to the vagus nerve, offering a unique approach to managing conditions such as cluster headaches and migraine. With a strong presence in North America and expanding operations in Europe, electroCore has established itself as a leader in the neuromodulation industry. The company’s commitment to research and development has led to notable achievements, including FDA approvals and clinical studies that underscore the efficacy of its therapies. As a result, electroCore continues to enhance patient care and redefine treatment paradigms in neurology.

DitchCarbon Score

How does electroCore, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

27

Industry Benchmark

electroCore, Inc.'s score of 26 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.

46%

Let us know if this data was useful to you

electroCore, Inc.'s reported carbon emissions

As of the latest available data, electroCore, Inc. has not reported any specific carbon emissions figures. However, the company has made significant climate commitments through the Science Based Targets initiative (SBTi). electroCore, Inc. aims to reduce its Scope 1 and Scope 2 greenhouse gas (GHG) emissions by 42% by the year 2030, using 2023 as the baseline year. This target is part of a near-term strategy that aligns with the 1.5°C climate goal, indicating a commitment to substantial emissions reductions in line with global climate objectives. Additionally, electroCore, Inc. plans to measure and address its Scope 3 emissions, which encompass indirect emissions from its value chain. These initiatives reflect the company's proactive approach to climate action, despite the absence of specific emissions data. The targets set are indicative of a broader commitment to sustainability and environmental responsibility within the industry context.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. electroCore, Inc.'s primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for electroCore, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

electroCore, Inc. is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Medtronic

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 8 days ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 24 hours ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Boston Scientific

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 8 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Abbvie

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251028.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy